Feprazone

非普拉宗

Report date: 2023/02/23 20:00:33
NME

Base Information

Drug NameFeprazone
Drug Alias Name非普拉崇feprazonafeprazonum非泼拉酮戊烯保泰松 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsToothacheRheumatic DiseasesPeriarthritis +[4] 
Global Approved IndicationsToothacheRheumatic DiseasesPeriarthritis +[4] 
Approved Indications in ChinaToothacheRheumatic DiseasesPeriarthritis +[4] 
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJinan Hengji Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsToothacheRheumatic DiseasesPeriarthritis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeM01AX18M02AA16
Related LinksWikipediaKEGG